Mink Therapeutics Inc (INKT) — Cash Flow-to-Debt Ratio
Mink Therapeutics Inc (INKT) has a Cash Flow-to-Debt Ratio of -0.03x as of September 2025, meaning its operating cash flow of $-941.35K could theoretically repay 0% of its total liabilities ($28.48 Million) in one year. Explore how efficiently does Mink Therapeutics Inc generate cash to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Mink Therapeutics Inc Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Mink Therapeutics Inc across 6 annual periods. Also explore INKT asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Mink Therapeutics Inc (2019–2024)
Year-by-year debt coverage analysis for Mink Therapeutics Inc. For market capitalisation and broader financial context, see Mink Therapeutics Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.38x | $-9.56 Million | $25.31 Million | ▲ +45.8% |
| 2023 | -0.70x | $-15.76 Million | $22.61 Million | ▲ +19.2% |
| 2022 | -0.86x | $-18.87 Million | $21.87 Million | ▼ -10.7% |
| 2021 | -0.78x | $-12.83 Million | $16.47 Million | ▼ -445.9% |
| 2020 | -0.14x | $-8.34 Million | $58.43 Million | ▲ +64.1% |
| 2019 | -0.40x | $-14.94 Million | $37.64 Million | — |